NCT03381651View on ClinicalTrials.gov

Different Radiation Dose of Neoadjuvant Chemoradiation for Resectable Thoracic Esophageal Squamous Carcinoma

NACompletedINTERVENTIONAL
Enrollment

147

Participants

Timeline

Start Date

February 22, 2018

Primary Completion Date

February 22, 2021

Study Completion Date

February 22, 2023

Conditions
Esophageal CarcinomaNeoadjuvant ChemoradiotherapySurgery
Interventions
RADIATION

Higher dose (50.4Gy/28F) of neoadjuvant chemoradiation

50.4Gy/28F radiation and concurrent chemotherapy with paclitaxel plus CBP used weekly

RADIATION

Lower dose (41.4Gy/23F) of neoadjuvant chemoradiation

41.4Gy/23F radiation and concurrent chemotherapy with paclitaxel plus CBP used weekly

Trial Locations (2)

310022

Zhejiang Cancer Hospital, Hangzhou

Unknown

Zhejiang Cancer Hospital, Hangzhou

All Listed Sponsors
lead

Zhejiang Cancer Hospital

OTHER

NCT03381651 - Different Radiation Dose of Neoadjuvant Chemoradiation for Resectable Thoracic Esophageal Squamous Carcinoma | Biotech Hunter | Biotech Hunter